Premium
Management of cutaneous T‐cell lymphomas: Established and emergent therapies
Author(s) -
Wain Thevaki,
Venning Victoria L,
Consuegra Germana,
FernandezPeñas Pablo,
Wells Jillian
Publication year - 2019
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.13011
Subject(s) - mycosis fungoides , medicine , lymphoma , dermatology , cutaneous lymphoma , cutaneous t cell lymphoma , treatment modality , pathology
Cutaneous T‐cell lymphoma is an uncommon group of non‐Hodgkin's lymphoma primarily affecting the skin. It is comprised of a variety of entities with different clinical behaviours and prognosis. Mycosis fungoides is the commonest subtype, and Sézary syndrome is a much rarer form of cutaneous T‐cell lymphoma. At this stage, control rather than cure is the goal of therapy, with particular emphasis placed on preserving quality of life. Our review of the efficacy, safety profile and accessibility of treatment modalities for mycosis fungoides/Sézary syndrome is a tailored guide for the clinician treating these rare conditions.